Immune checkpoint blocking impact and nomogram prediction of COVID-19 inactivated vaccine seroconversion in patients with cancer: a propensity-score matched analysis

BACKGROUND: Patients with cancer on active immune checkpoint inhibitors therapy were recommended to seek prophylaxis from COVID-19 by vaccination. There have been few reports to date to discuss the impact of progression cell death-1 blockers (PD-1B) on immune or vaccine-related outcomes, and what ri...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Yifei, Liu, Nianqi, Wang, Youlong, Zeng, Jiling, Hu, Ying-Ying, Hao, Wu, Shi, Huazheng, Zhu, Pengfei, Lv, Jun, Fan, Wei, Wang, Xinjia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Clinical/Translational Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8634011/
https://www.ncbi.nlm.nih.gov/pubmed/34845005
http://dx.doi.org/10.1136/jitc-2021-003712

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8634011/
https://www.ncbi.nlm.nih.gov/pubmed/34845005
http://dx.doi.org/10.1136/jitc-2021-003712

Ejemplares similares